Labcyte to be acquired by Beckman Coulter Life Sciences

Beckman Coulter Life Sciences has announced the purchase of the acoustic liquid handling company Labcyte, best known for its Echo® acoustic droplet ejection technology. The latter will move into Beckman under the Danaher Life Sciences platform.
Chief technology officer and founder of Labcyte, Richard Ellson, said: “It has been an exciting journey, from developing acoustic liquid-dispensing technology in a garage to establishing a global presence, and now to be joining forces with a life sciences technology leader. Acoustic liquid handling is quickly becoming the backbone for high-throughput, automated workflows, and we look forward to accelerating growth and innovation as part of the Beckman Coulter Life Sciences team.”
Beckman Coulter Life Sciences’ president, Jonathan Pratt, said: “Labcyte’s unique product portfolio complements our existing liquid handling and laboratory automation business. It provides new opportunities to develop and enhance time-saving solutions for customer workflows. Labcyte and Beckman Coulter Life Sciences share a common vision of advancing science through discovery, enabling the faster discovery and development of life-changing advances in medicine. Together we will make a powerful team, and an invaluable resource for current and future customers around the world.”